Las Vegas Plastic Surgery: Jeffrey J. Roth M.D. F.A.C.S.
Las Vegas Plastic Surgery

By

Xeomin,  manufactured by Merz Pharmaceuticals, LLC.  of Greensboro, North Carolina, has received FDA approval to be sold in the United States.  The FDA has approved the drug to treat Cervical Dystonia, a disease related to abnormal head position, and blepharospasm, which causes  muscle spasms around the eyes.  Xeomin works the same way that  Botox and Dysport do by relieving the muscles that cause wrinkles and “frown lines” in the face.  There is no official word yet if Xeomin will be available for cosmetic use anytime soon. If Xeomin is approved for use in cosmetic procedures it could become a competitor for Botox.

If you are interested in learning more about Xeomin or cosmetic face and skin treatments, please feel free to call or e-mail my office with any questions.

Jeffrey J. Roth, M.D., F.A.C.S.

Las Vegas Plastic Surgery

(702) 450-0777

www.jjrothmd.com

References:

https://www.merzusa.com/pdf/FDA_Approval_of_Xeomin.pdf

https://www.botoxmedical.com/

https://www.botoxcosmetic.com/home.aspx

https://www.botoxseveresweating.com/

https://www.dysport.com/

https://www.drugs.com/newdrugs/fda-approves-dysport-therapeutic-aesthetic-uses-1336.html

Comments are closed.

Contact